ask="18.62"
ask_size="2000"
average_daily_volume="327695"
bid="17.98"
bid_size="300"
book_value="3.21"
change="+0.17"
change_from_200_day_moving_average="5.09"
change_from_50_day_moving_average="0.54"
change_from_52_week_high="-5.02"
change_From_52_week_low="13.41"
change_in_percent="+0.95%"
close="18.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7736000"
high="18.33"
high_52_weeks="23.07"
last_trade_date="2/3/2017"
last_trade_price="18.05"
last_trade_size="3299"
last_trade_time="4:00pm"
low="17.82"
low_52_weeks="4.64"
market_capitalization="179.65M"
moving_average_200_day="12.96"
moving_average_50_day="17.51"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="17.94"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+39.26%"
percent_change_from_50_day_moving_average="+3.09%"
percent_change_from_52_week_high="-21.76%"
percent_change_from_52_week_low="+289.01%"
previous_close="17.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.57"
price_per_sales="3148.39"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="7.19"
stock_exchange="NGM"
symbol="ZYNE"
volume="470010"
weeks_range_52="4.64 - 23.07"
